Lv6
2759 积分 2021-01-15 加入
Discovery of a Highly Potent and Selective ENL Degrader
11天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
11天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
22天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
22天前
已完结
TBAI-Mediated Cyclization and Methylsulfonylation of Propargylic Amides with Dimethyl Sulfite
25天前
已完结
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
1个月前
已完结
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR
1个月前
已完结
Cathepsin B-Responsive Phosphatidylinositol 3-Kinase (PI3K) Prodrug for the Treatment of Pulmonary Fibrosis
1个月前
已关闭
The role of hydrophilic linkers in next-generation antibody-drug conjugates
1个月前
已完结
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo
1个月前
已完结
皖公网安备34019202002308
